Interaction Color Code
Clinical Bottom Line
Do not coadminister: Reduced levels of etravirine
Drug 1
Drug 1 dose
200 mg daily x 2 weeks then 200 mg BID x 2 weeks
Drug 1 effect
levels): increased 15-30%
Drug 2
Drug 2 effect
Etravirine AUC decreased 55%
Clinical Effects
Decreased etravirine and nevirapine effects
Management
Use alternative agents
Import ID
617
